RayzeBio, Inc. Common Stock
RayzeBio, Inc. Common Stock (RYZB) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001825367 · RYZB · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001825367 · Updated hourly · Not investment advice
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
RayzeBio, Inc. Common Stock (NASDAQ: RYZB) has submitted 105 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2023. As a Healthcare sector company with CIK 0001825367, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is RayzeBio, Inc. Common Stock's most comprehensive regulatory disclosure. The most recent RayzeBio, Inc. Common Stock 10-K was filed on — for fiscal year ending —. Historical RYZB 10-K annual reports are available from 2020 through —.
Investors researching RayzeBio, Inc. Common Stock SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
RYZB SEC Filings · 8 questionsRayzeBio, Inc. Common Stock (RYZB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 105 filings and access original documents at no cost. RayzeBio, Inc. Common Stock's CIK is 0001825367.